New England Capital Financial Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $984 | Hold |
475
| – | – | ﹤0.01% | 365 |
|
|
2025
Q1 | $1.05K | Hold |
475
| – | – | ﹤0.01% | 336 |
|
|
2024
Q4 | $727 | Hold |
475
| – | – | ﹤0.01% | 365 |
|
|
2024
Q3 | $946 | Hold |
475
| – | – | ﹤0.01% | 345 |
|
|
2024
Q2 | $1.66K | Hold |
475
| – | – | ﹤0.01% | 324 |
|
|
2024
Q1 | $1.32K | Hold |
475
| – | – | ﹤0.01% | 329 |
|
|
2023
Q4 | $808 | Hold |
475
| – | – | ﹤0.01% | 350 |
|
|
2023
Q3 | $490 | Hold |
475
| – | – | ﹤0.01% | 359 |
|
|
2023
Q2 | $551 | Hold |
475
| – | – | ﹤0.01% | 353 |
|
|
2023
Q1 | $718 | Hold |
475
| – | – | ﹤0.01% | 388 |
|
|
2022
Q4 | $1.4K | Buy |
+475
| New | +$1.4K | ﹤0.01% | 364 |
|